Professional Summary
Professional Overview
Ben Watt is an experienced financial executive with a proven track record of driving strategic growth and operational excellence. As the Group Chief Financial Officer at SERB Specialty Pharmaceuticals, he is responsible for overseeing the company's global financial operations, planning, and reporting to support the organization's ambitious expansion plans.
Experience Summary
Current Role
As the Group CFO at SERB Specialty Pharmaceuticals, Ben is responsible for leading the company's financial strategy, ensuring financial discipline, and supporting the executive team in achieving their strategic objectives. He oversees all aspects of financial management, including budgeting, forecasting, investment decisions, and risk mitigation, while also playing a key role in mergers, acquisitions, and integration initiatives.
Career Progression
Prior to his current role, Ben held several senior finance positions, including Chief Financial Officer at Crouzet, where he was instrumental in driving the company's operational and financial transformation, and Vice-President of Global Financial Reporting and Accounting at Custom Sensors & Technologies (CST), where he led the integration of acquired companies and implemented robust financial systems and controls.
Earlier in his career, Ben served as a Director at Eight Advisory and Maidencraig Investments, providing strategic financial advisory services to clients across various industries. He also gained valuable experience as a Financial Advisor to the CEO and CFO at Damovo Group, and as a Manager in the Transaction Advisory Services practice at Arthur Andersen & Co.
Academic Background
Ben holds a Bachelor's degree in Accounting and Finance from the University of Exeter, where he graduated with distinction.
Areas of Expertise
- Financial strategy and planning
- Mergers, acquisitions, and integration
- Financial reporting and control
- Risk management and mitigation
- Operational optimization and transformation
- Cross-functional leadership and collaboration
Professional Impact
Throughout his career, Ben has demonstrated a keen ability to drive financial excellence and support the strategic initiatives of the organizations he has served. His expertise in integrating acquired companies, implementing robust financial systems, and optimizing operational performance has delivered tangible value and positioned his previous employers for sustainable growth.
Conclusion
With his extensive finance background, strategic mindset, and proven track record of success, Ben Watt is well-equipped to lead the financial operations of SERB Specialty Pharmaceuticals and contribute to the company's continued growth and market leadership.
